GetTopicDetailResponse(id=70f3949e5f6, topicName=造影劑Vizamyl, introduction=造影劑Vizamyl, content=null, image=null, comments=1, allHits=342, url=https://h5.medsci.cn/topic?id=94975, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=14539, tagList=[TagDto(tagId=14539, tagName=造影劑Vizamyl)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1814283, encodeId=7643181428313, content=<a href='/topic/show?id=70f3949e5f6' target=_blank style='color:#2F92EE;'>#造影劑Vizamyl#</a>, objectTitle=FDA批準腦部造影劑Vizamyl用于AD和癡呆癥患者評價, objectType=article, longId=25901, objectId=e75825901c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e75825901c2, replyNumber=0, likeNumber=0, createdTime=2014-04-17, rootId=0, userName=zhanfl, userId=3138208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e75825901c2, moduleTitle=FDA批準腦部造影劑Vizamyl用于AD和癡呆癥患者評價, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e75825901c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
